Ask us a question
520 547-3440
info@c-path.org
Subscribe
Home
About
HOW WE OPERATE
Breadth of Expertise
Core Competencies
Timeline
People
FAQs
Employment
Annual Reports
Programs
Sharing Knowledge that Leads to Innovation
ACTIVE CONSORTIA / PROGRAMS
BmDR
Biomarker Data Repository
MSOAC
Multiple Sclerosis Outcome Assessments Consortium
CPAD
Critical Path for Alzheimer’s Disease
PRO Consortium
Patient-Reported Outcome Consortium
CPP
Critical Path for Parkinson’s
PKDOC
Polycystic Kidney Disease Outcomes Consortium
CP-RND
Critical Path for Rare Neurodegenerative Diseases
PredicTox KE
PredicTox Knowledge Environment
CP-SCD
Critical Path for Sickle Cell Disease
PSTC
Predictive Safety Testing Consortium
CPTA
Critical Path to Therapeutics for the Ataxias
QuantMed
Quantitative Medicine Program
CDRC
CURE Drug Repurposing Collaboratory
RDCA-DAP
Rare Disease Cures Accelerator-Data and Analytics Platform
DCC
Data Collaboration Center
RD-COA Consortium
Rare Disease Clinical Outcome Assessment Consortium
D-RSC
Duchenne Regulatory Science Consortium
TB-PACTS
TB-Platform for Aggregation of Clinical TB Studies
eCOA Consortium
Electronic Clinical Outcome Assessment Consortium
TTC
Transplant Therapeutics Consortium
FA-ICD
Friedreich’s Ataxia Integrated Clinical Database
TOMI-T1D
Trial Outcome Markers Initiative in T1D Consortium
HD-RSC
Huntington’s Disease Regulatory Science Consortium
TRxA
Translational Therapeutics Accelerator
INC
International Neonatal Consortium
T1D
Type 1 Diabetes Consortium
Completed Consortia
CFAST
Coalition for Accelerating Standards & Therapies
PTC
Pediatric Trials Consortium
CPTR
Critical Path to TB Drug Regimens
C-Path in Europe
Tools & Platforms
Impact
Impact Stories
Successes
Evidentiary Considerations
Training
News & Events
Events
News
Videos
Publications
Presentations
Press Releases
Make a Gift
TTC
Home
>
News & Events
>
Presentations
>
TTC
News & Events
September 4, 2020
Transplant Therapeutics Consortium Impact on Drug Development
Refine:
Period
Program
All Programs
TTC - Transplant Therapeutics Consortium
CP-RND - Critical Path for Rare Neurodegenerative Diseases
TRxA - Translational Therapeutics Accelerator
RD-COA Consortium - Rare Disease Clinical Outcome Assessment Consortium
CPTA - Critical Path to Therapeutics for the Ataxias
PredicTox KE - PredicTox Knowledge Environment
CP-SCD - Critical Path for Sickle Cell Disease
CDRC - CURE Drug Repurposing Collaboratory
QuantMed - Quantitative Medicine Program
TOMI-T1D - Trial Outcome Markers Initiative in T1D
RDCA-DAP - Rare Disease Cures Accelerator-Data and Analytics Platform
HD-RSC - Huntington’s Disease Regulatory Science Consortium
T1D - Type 1 Diabetes Consortium
CPAD - Critical Path for Alzheimer's Disease
BmDR - Biomarker Data Repository
CFAST - Coalition For Accelerating Standards and Therapies
CPP - Critical Path for Parkinson's
CPTR - Critical Path to TB Drug Regimens
DCC - Data Collaboration Center
D-RSC - Duchenne Regulatory Science Consortium
INC - International Neonatal Consortium
MSOAC - Multiple Sclerosis Outcome Assessments Consortium
PKD - Polycystic Kidney Disease Outcomes Consortium
PRO Consortium - Patient-Reported Outcome Consortium
eCOA Consortium - Electronic Clinical Outcome Assessment Consortium
PSTC - Predictive Safety Testing Consortium
PTC - Pediatric Trials Consortium
TB-PACTS - TB-Platform for Aggregation of Clinical TB Studies
Category
News
Press Releases
Presentations
Publications
Events
Videos
Announcements
Webcasts
Tags
ADPKD/PKD
Alzheimer's
Biomarker
C-Path employees/board
CDISC Standards/TAUGs
Clinical Trials/COAs
Community/Arizona
Crohn's disease
Database/Data Collaboration
Drug Safety/Safety Testing
Duchenne
Europe
Funding
Genetics
Huntington's
Modeling and Simulation
Multiple Sclerosis/MS
Neonatal/Pediatric
Parkinson's
Patient Reported Outcome
PRO Consortium
Regulatory/EMA/FDA/PMDA
Transplant
TTC
Tuberculosis/TB
Type 1 diabetes
x
Contact Us
Name
Email
Phone
Message
x
Contact Us
Name
Email
Phone
Message
x
Contact Us
Name
Email
Phone
Message
x